Clinical Trial Update: Exploratory Investigation of Motilium's Effectiveness and Safety for the OTC Treatment of Dyspepsia-related Symptoms

View source ↗

Summary

A completed exploratory clinical trial assessing the effectiveness and safety of Motilium (domperidone) for OTC treatment of dyspepsia-related symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• Motilium (domperidone)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Dyspepsia | Status: COMPLETED